Intravesical gemcitabine protocol

    • [DOCX File]Montefiore Medical Center

      https://info.5y1.org/intravesical-gemcitabine-protocol_1_88f771.html

      Intravesical Gemcitabine therapy for BCG refractory superficial bladder cancer: A Phase I/II study. Principal investigator: M Schoenberg, M.D. Carcinoma in Situ in Patients with Bladder Cancer. Photocure. M Droller, M.D., MP Schoenberg, M.D. (Begins 9/1/2001)

      gemcitabine docetaxel intravesical protocol


    • [DOC File]Journal of Cancer

      https://info.5y1.org/intravesical-gemcitabine-protocol_1_38cf3b.html

      The clinical tumor stage, tumor grade and intravesical instillation protocol of each patient were in accordance with the “Chinese Diagnosis and Treatment of Urological Diseases Guide” [18]. Hydroxycamptothecin, Epirubicin, pyirubicin and gemcitabine were used for perfusion.

      intravesical chemotherapy protocol


    • Overview | Sesen Bio

      Vicinium is administered by intravesical administration directly into the bladder. Vicinium utilizes an immunogenic cytotoxic protein payload that is a truncated form of ETA produced by the bacterial species ... Eli Lilly and Company (Gemcitabine) and Telormedix SA (Vesimune); ... complying with the study protocol and investigational plan ...

      gemcitabine bladder instillation procedure


    • Massachusetts Cancer Registry

      2. If the patient is treated according to a facility's standards of practice or established protocol or is managed within accepted management guidelines for the given type of case, First Course ends with completion of these treatments. 3.

      gemcitabine docetaxel bladder instillation


    • Mass.Gov

      J9031 BCG (intravesical) per instillation. J9035 Injection, bevacizumab, 10 mg . ... J9201 Injection, gemcitabine HC1, 200 mg. J9202 Goserelin acetate implant, per 3.6 mg (PA) J9206 Injection, irinotecan, 20 mg. ... project or treatment protocol, per encounter.

      gemcitabine for bladder cancer


    • [DOCX File]Australian Public Assessment Report for Atezolizumab

      https://info.5y1.org/intravesical-gemcitabine-protocol_1_8f109f.html

      The efficacy results for Cohort 2 at the data cut-off date of 5 May 2015 were the protocol-defined primary analysis for this cohort. The data at this cut-off date allowed for at least 24 weeks of follow-up for the last enrolled patient, and the median length of follow-up for the enrolled patients was 7.1 months.

      gemcitabine bladder instillation dosing


    • Emerging Therapies for Superficial Bladder Cancer

      Intravesical therapy has also been employed in an induction and/or maintenance fashion to provide long-term immuno-stimulation of chemotoxicity in an effort to prevent disease recurrence[6].

      gemcitabine intravesical dosage


    • [DOC File]APPLICATION FOR

      https://info.5y1.org/intravesical-gemcitabine-protocol_1_f77f11.html

      Dual variable domain immunoglobulins and uses thereof. Cross Reference to Related Applications. This application is a non-provisional application claiming priority to U.S. Provisional Application Serial No. 61/410,166, filed November 4, 2010, the entire content of which is hereby incorporated by reference.

      gemcitabine bladder instillation protocol


    • [DOC File]MEDICIS REPORT - Pacific Bridge Medical

      https://info.5y1.org/intravesical-gemcitabine-protocol_1_362600.html

      In order to develop a protocol of clinical trials to be conducted in Japan, a company should identify key doctors who will conduct the study, as well as a Contract Research Organization (CRO) that will lead the study. ... Designated Company 7/10/1996 Freeze-dried BCG Immunobladder intravesical Superficial bladder cancer, carcinoma in situ of ...

      gemcitabine docetaxel intravesical protocol


    • [DOC File]Current strategies in the treatment of non-muscle invasive ...

      https://info.5y1.org/intravesical-gemcitabine-protocol_1_5f79aa.html

      The place of gemcitabine and possible advantages over other intravesical drugs remains uncertain (49). Optimising intravesical chemotherapy One randomised trial has demonstrated that adapting urinary pH, decreasing urinary excretion and buffering the intravesical solution reduce the recurrence rate (50) .

      intravesical chemotherapy protocol


Nearby & related entries: